ACHL - Achilles Therapeutics GAAP EPS of -$0.44 beats by $0.13 August, 09 2022 08:45 AM Achilles Therapeutics plc Achilles Therapeutics press release ( NASDAQ: ACHL ): Q2 GAAP EPS of -$0.44 beats by $0.13 . Cash and cash equivalents: Cash and cash equivalents were $201.6 million as of Q2 For further details see: Achilles Therapeutics GAAP EPS of -$0.44 beats by $0.13